Rociletinib hydrobromide
Rociletinib hydrobromide is an oral kinase inhibitor that selectively targets EGFR L858R/T790M mutant (Ki 21.5 nM) over wild-type EGFR (Ki 303.3 nM) . It is a research tool for investigating resistance mechanisms in non-small cell lung cancer, applicable in both in vitro biochemical assays and in vivo xenograft models.
Product Specifications
CAS Number
1446700-26-0
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
Br.COc1cc (ccc1Nc1ncc (c (Nc2cccc (NC (=O) C=C) c2) n1) C (F) (F) F) N1CCN (CC1) C (C) =O
Molecular Formula
C27H29BrF3N7O3
Molecular Weight
636.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15193657 1 Vial
Lentiviral mouse Sumf2 shRNA (UAS) - Lentiviral mouse Sumf2 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
LV779419 1.0 µg DNA
RPL30P5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details 